Oncologists Accepting CurativePage 4
2,173 verified oncologists across the U.S. accept Curative. Profiles cover focus areas including Neuro-Oncology, Medical Oncology, and Breast Oncology. Common hospital affiliations include Duke University Hospital, Duke Cancer Institute, and NewYork-Presbyterian Hospital.


Carey Anders, MD
Professor of Medicine; Medical Director, Duke Center for Brain and Spine Metastases; Former Chief, Division of Medical Oncology
Oncology


Jedd Wolchok, MD
Meyer Director, Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine
Oncology


Erica Mayer, MD MPH
Assistant Professor, Medicine, Brigham and Women's Hospital, Harvard Medical School; Director, Breast Cancer Clinical Research, Dana-Farber Breast Oncology Program
Oncology


Richard Ambinder, M.D.
James B. Murphy Professor of Oncology and Director, Division of Hematologic Malignancies, Johns Hopkins Kimmel Cancer Center
Oncology


Sarat Chandarlapaty, M.D., PH.D.
Breast Medical Oncologist; Naddisy Foundation Chair in Breast Cancer Research at Memorial Sloan Kettering; Section Head for Translational Research, Breast Service, Department of Medicine; Director, Developmental Research Program, MSK Breast SPORE; Member and Lab Head, Human Oncology and Pathogenesis Program
Oncology


Tanguy Seiwert, M.D.
Director, Head and Neck Cancer Oncology Disease Program; Co-Director, Bloomberg~Kimmel Institute for Immunotherapy; Assistant Professor of Oncology, Johns Hopkins University School of Medicine
Oncology


Samuel Denmeade, M.D.
R. Dale Hughes Professor of Oncology and Director, Genitourinary Oncology Program, Johns Hopkins University School of Medicine
Oncology


Jay Acharya, MD
Associate Professor of Radiology, David Geffen School of Medicine at UCLA
Oncology


Ravi Vij, MD
Oncology


David Solit, MD
Director, Marie-Josée and Henry R. Kravis Center for Molecular Oncology; Attending Physician, Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center
Oncology


Jill Langer, MD
Chief of Ultrasound Section; Professor of Radiology at the Hospital of the University of Pennsylvania; Vice Chair of Faculty Affairs, Department of Radiology; Section Chief, Ultrasound
Oncology


Ajay Gopal, MD
Professor, Division of Hematology and Oncology, University of Washington; Professor, Clinical Research Division, Fred Hutch Cancer Center; Director of Clinical Research, Hematologic Malignancies/Hematology, Fred Hutch / UW Cancer Consortium; Stephen H. Petersdorf Endowed Chair in Cancer Care
Oncology


David Ettinger, M.D.
Alex Grass Professor of Oncology, Professor of Medicine, Otolaryngology-Head and Neck Surgery, Gynecology and Obstetrics, and Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine
Oncology


William Mayo-Smith, MD
Professor of Radiology
Oncology


Alan Venook, MD
Madden Family Distinguished Professor of Medical Oncology and Translational Research; Shorenstein Associate Director for Program Development, Helen Diller Family Comprehensive Cancer Center; Professor, Department of Medicine (Hematology/Oncology)
Oncology


Tina Cascone, M.D., PH.D.
Section Chief, Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas; Associate Professor, Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Oncology


Edward Lee, MD
Professor, Division of Interventional Radiology, Department of Radiology and Division of Liver and Pancreas Transplant Surgery; Director of IR Residency Program, Director of Research, and Director of Lymphatic Intervention at UCLA
Oncology


Atif Zaheer, MD
Associate Professor of Radiology and Radiological Science; Associate Program Director, Diagnostic Radiology Residency; Director, Cross-Sectional Imaging Fellowship; Medical Director, e-Radiology Learning Program
Oncology


David Hong, M.D.
Professor (tenure), Department of Investigational Cancer Therapeutics, Division of Cancer Medicine; Deputy Chair, Department of Investigational Cancer Therapeutics
Oncology


Ann Partridge, MD MPH
Chief Clinical Strategy Officer, Vice Chair of Medical Oncology, and founder and director of Young and Strong, the Program for Young Adults with Breast Can; Chair in Breast Cancer Research at Dana-Farber. She conducts clinical research focused on improving cancer care and outcomes with a particular focus on you
Oncology
Oncologists accepting Curative by state
Find oncologists who accept Curative in your state.